Market Closed -
Toronto S.E.
15:43:05 2024-05-10 EDT
|
5-day change
|
1st Jan Change
|
0.78
CAD
|
0.00%
|
|
+2.63%
|
-6.02%
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
109.5
|
70.09
|
149
|
118.4
|
90.41
|
Enterprise Value (EV)
1 |
96.27
|
75.25
|
161.7
|
154.7
|
131.9
|
P/E ratio
|
-7.74
x
|
-5.43
x
|
-85.1
x
|
135
x
|
12.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
52.2
x
|
27.5
x
|
8.75
x
|
3.3
x
|
1.58
x
|
EV / Revenue
|
45.9
x
|
29.5
x
|
9.5
x
|
4.32
x
|
2.3
x
|
EV / EBITDA
|
-10.1
x
|
-8.09
x
|
58.7
x
|
17.9
x
|
7.98
x
|
EV / FCF
|
-3,920,257
x
|
-4,323,521
x
|
-4,799,164
x
|
-6,476,728
x
|
-11,451,361
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
2.32
x
|
1.83
x
|
2.32
x
|
1.77
x
|
1.13
x
|
Nbr of stocks (in thousands)
|
70,677
|
73,774
|
87,648
|
87,698
|
90,407
|
Reference price
2 |
1.550
|
0.9500
|
1.700
|
1.350
|
1.000
|
Announcement Date
|
19-11-28
|
20-12-15
|
21-12-08
|
22-11-25
|
23-12-07
|
Fiscal Period: August |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.8653
|
2.097
|
2.551
|
17.02
|
35.84
|
57.26
|
EBITDA
1 |
-3.464
|
-9.497
|
-9.302
|
2.753
|
8.623
|
16.53
|
EBIT
1 |
-3.634
|
-9.922
|
-11.54
|
0.0526
|
4.819
|
11.72
|
Operating Margin
|
-420.01%
|
-473.16%
|
-452.44%
|
0.31%
|
13.45%
|
20.46%
|
Earnings before Tax (EBT)
1 |
-4.226
|
-12.97
|
-13.09
|
-1.528
|
2.305
|
6.945
|
Net income
1 |
-4.226
|
-12.32
|
-12.48
|
-1.528
|
2.305
|
6.945
|
Net margin
|
-488.38%
|
-587.28%
|
-489.35%
|
-8.98%
|
6.43%
|
12.13%
|
EPS
2 |
-0.1171
|
-0.2003
|
-0.1750
|
-0.0200
|
0.0100
|
0.0778
|
Free Cash Flow
|
-
|
-24.56
|
-17.4
|
-33.7
|
-23.88
|
-11.52
|
FCF margin
|
-
|
-1,171.04%
|
-682.31%
|
-198.01%
|
-66.63%
|
-20.12%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18-10-25
|
19-11-28
|
20-12-15
|
21-12-08
|
22-11-25
|
23-12-07
|
Fiscal Period: August |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.13
|
-
|
5.16
|
12.7
|
36.3
|
41.5
|
Net Cash position
1 |
-
|
13.3
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.0367
x
|
-
|
-0.5551
x
|
4.626
x
|
4.207
x
|
2.511
x
|
Free Cash Flow
|
-
|
-24.6
|
-17.4
|
-33.7
|
-23.9
|
-11.5
|
ROE (net income / shareholders' equity)
|
-
|
-40.1%
|
-29.7%
|
-2.98%
|
3.52%
|
9.48%
|
ROA (Net income/ Total Assets)
|
-
|
-12.8%
|
-11.7%
|
0.04%
|
2.77%
|
5.48%
|
Assets
1 |
-
|
96.28
|
106.4
|
-3,419
|
83.29
|
126.7
|
Book Value Per Share
2 |
0.3100
|
0.6700
|
0.5200
|
0.7300
|
0.7600
|
0.8800
|
Cash Flow per Share
2 |
0.2700
|
0.3800
|
0.1100
|
0.0900
|
0.1400
|
0.0500
|
Capex
1 |
27.9
|
23
|
9.18
|
31.1
|
15.5
|
9.88
|
Capex / Sales
|
3,226.58%
|
1,097.44%
|
359.94%
|
182.57%
|
43.15%
|
17.25%
|
Announcement Date
|
18-10-25
|
19-11-28
|
20-12-15
|
21-12-08
|
22-11-25
|
23-12-07
|
|
1st Jan change
|
Capi.
|
---|
| -6.02% | 51.39M | | -.--% | 339M | | +33.33% | 261M | | +39.53% | 182M | | +164.52% | 150M | | -33.33% | 137M | | +50.41% | 136M | | -28.57% | 121M | | -7.69% | 80.3M | | +100.00% | 60.26M |
Medical Farming
|